Bradykinin B1 receptor antagonists: a patent update 2009 – 2012

Author： Bozó Éva   Éles János   Keserű György M  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.12, 2012-12, pp. : 1443-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bradykinin B1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1479-1482

Informa Healthcare

Access to resources Recommend Favorite

Differential modulation of murine lung inflammation by bradykinin B 1 and B 2 selective receptor antagonists

By Gama Landgraf R.   Sirois P.   Jancar S.  

European Journal of Pharmacology, Vol. 460, Iss. 1, 2003-01 ,pp. : 75-83

Elsevier

Access to resources Recommend Favorite

Bradykinin receptor antagonists – a review of the patent literature 2005 – 2008

By Fincham Christopher I   Bressan Alessandro   Paris Marielle   Rossi Cristina   Fattori Daniela  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 7, 2009-07 ,pp. : 919-941

Informa Healthcare

Access to resources Recommend Favorite

Bradykinin B1 Receptor Antagonists as Novel Analgesics: A Retrospective of Selected Medicinal Chemistry Developments

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1420-1430

Bentham Science Publishers

Access to resources Recommend Favorite

AT1 antagonists: a patent review (2008 – 2012)

By Mavromoustakos Thomas   Agelis George   Durdagi Serdar  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1483-1494

Informa Healthcare

Access to resources Recommend Favorite